Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Incontinence, Urinary: later-stage trial registry
3 of 4 indexed Incontinence, Urinary trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Incontinence, Urinary: 4 US clinical trials tracked, 3 recruiting.
Incontinence, Urinary is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Valencia Technologies Corporation, running 1 of these trials.
Enrollment posture brief
Registry condition incontinence-urinary
OPEN 3 | RECR 75% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Incontinence, Urinary lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Incontinence, Urinary on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Incontinence, Urinary is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
TReating Incontinence for Underlying Mental and Physical Health
University of California, San Francisco
NCT05362292
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
NCT05685433
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
University of South Florida
NCT04305743
A Prospective Case Series Analysis of Initial Users of the Urovac Device
Cedars-Sinai Medical Center
NCT03872518
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Incontinence, Urinary records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Incontinence, Urinary trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Incontinence, Urinary page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Incontinence, Urinary trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Valencia Technologies Corporation sponsors the most Incontinence, Urinary trials on record, review their full trial history before evaluating a specific study. See Valencia Technologies Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Incontinence, Urinary condition card totals 4 registered trials; most-linked intervention Urovac; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.